[Contrast medium induced nephropathy: pathogenesis, clinical aspects, prevention].
Haller
C
C
Abteilung III mit Schwerpunkt Kardiologie, Angiologie, Pneumologie, Universität Heidelberg. challer@med.uni-heidelberg.de
Kübler
W
W
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control; D003287:Contrast Media / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004232:Diuretics / Q000627:therapeutic use; D004234:Diuretics, Osmotic / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D008353:Mannitol / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000627:therapeutic use; D011379:Prognosis; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D003287:Contrast Media; D004232:Diuretics; D004234:Diuretics, Osmotic; D010952:Plasma Substitutes; D008353:Mannitol; D005665:Furosemide